Broadstone Net Lease, Inc. (NYSE: BNL) (“BNL”, the “Company”,
“we”, “our”, or “us”), today announced its operating results for
the year and quarter ended December 31, 2023, and its healthcare
portfolio simplification strategy.
MANAGEMENT COMMENTARY
“I am incredibly proud of our 2023 results, which we were able
to deliver despite significant economic headwinds and capital
market volatility through the year. We thoughtfully navigated a
challenging environment by intentionally focusing on portfolio
composition and quality which we believe will be the catalyst for
increasing shareholder value as markets stabilize,” said John
Moragne, BNL’s Chief Executive Officer. “We employed a disciplined
and selective approach to all aspects of our investment cycle:
intentionally evading risk and creatively sourcing investment
opportunities that were created by the distressed lending
environment and complementary to our core competencies and asset
classes; maintaining a high quality portfolio of diversified
properties with strong operating metrics; pruning tenant credit
risk and lease rollover risk through selective dispositions with
attractive spreads to redeployment yields; and maintaining a
fortified investment grade balance sheet with low leverage at 5.0x,
no material debt maturities until 2026, and ample liquidity to
capitalize on additional investment opportunities. As a result, we
were able to achieve $1.41 per share of AFFO, in line with the
midpoint of our guidance range.”
FULL YEAR 2023 HIGHLIGHTS
INVESTMENT
ACTIVITY
- We completed investments totaling $165.6 million, including
$97.2 million in development fundings, $42.8 million in revenue
generating capital expenditures, and $25.6 million in new property
acquisitions. The revenue generating capital expenditures and new
property acquisitions had a weighted average initial cash
capitalization rate of 7.2%, lease term of 15.5 years, and annual
rent increase of 1.8%.
- In 2023 and through the date of this release, we sold 14
properties for gross proceeds of $200.1 million at a weighted
average cash capitalization rate of 6.0% on tenanted properties.
The gross proceeds represented a $35.0 million gain over original
purchase price.
- Subsequent to year-end, we invested an additional $12.3 million
in development fundings and $3.0 million in revenue generating
capital expenditures. As of the date of this release, we have $97.1
million of acquisitions under control, $98.9 million of commitments
to fund developments, and $6.8 million of commitments to fund
revenue generating capital expenditures with existing tenants.
- Subsequent to year end, we executed contracts to sell 37
clinical, surgical, and traditional medical office building (“MOB”)
properties for approximately $253.0 million at a weighted average
cash capitalization rate of 7.9%. The agreed upon sales price
represents a gain of $0.8 million over their original purchase
price. See Healthcare Portfolio Simplification Strategy section
below for additional information.
OPERATING
RESULTS
- Collected 99.8% of base rents due for the year for all
properties under lease.
- Portfolio was 99.4% leased based on rentable square footage,
with only two of our 796 properties vacant and not subject to a
lease at year end.
- Incurred $39.4 million of general and administrative expenses,
inclusive of $6.0 million of stock-based compensation and $1.6
million of severance and executive transition costs.
- Generated net income of $163.3 million, or $0.83 per
share.
- Generated adjusted funds from operations (“AFFO”) of $277.7
million, or $1.41 per share, in-line with the midpoint of our
guidance range.
CAPITAL MARKETS ACTIVITY
- Ended the year with total outstanding debt of $1.9 billion, Net
Debt of $1.9 billion, and a Net Debt to Annualized Adjusted
EBITDAre ratio (“Leverage Ratio”) of 5.0x.
- At December 31, 2023, had $909.6 million of capacity on our
Revolving Credit Facility.
- At December 31, 2023, had $145.4 million of capacity remaining
on our at-the-market common equity offering (“ATM Program”).
- On March 14, 2023, our board of directors approved a $150.0
million common stock repurchase program. We did not repurchase any
shares under the Repurchase Program during the year.
- Declared dividends of $1.12 in 2023, representing a 3.7%
increase over prior year.
- At its February 16, 2024, meeting, our Board of Directors
declared a quarterly dividend of $0.285 per common share and OP
Unit to holders of record as of March 29, 2024, payable on or
before April 15, 2024.
FOURTH QUARTER 2023 HIGHLIGHTS
INVESTMENT ACTIVITY
- During the fourth quarter, we invested $64.1 million in three
industrial properties and two restaurant properties, including
$47.9 million in both new and existing development fundings and
$16.2 million in revenue generating capital expenditures. Revenue
generating capital expenditures had a weighted average initial cash
capitalization rate of 7.5%, lease term of 12.7 years, and annual
rent increase of 1.5%.
- During the fourth quarter, we sold five properties for gross
proceeds of $16.5 million at a weighted average cash capitalization
rate of 6.7%, representing a $5.3 million gain over their original
purchase price.
OPERATING
RESULTS
- Collected 99.2% of base rents due for the fourth quarter for
all properties subject to a lease. Outstanding base rents relate
solely to Green Valley Medical Center, whereby rents were scheduled
to commence in October 2023.
- Incurred $9.4 million of general and administrative expenses,
inclusive of $1.4 million of stock-based compensation and $0.2
million of severance and executive transition costs.
- Generated net income of $6.8 million, or $0.03 per diluted
share.
- Generated AFFO of $71.3 million, or $0.36 per share.
HEALTHCARE PORTFOLIO SIMPLIFICATION STRATEGY
Subsequent to quarter end, we made the strategic decision to
sell our clinically-oriented healthcare properties, furthering our
focus on core net lease assets in the industrial, retail, and
restaurant sectors. The assets identified for sale are not
customarily included in single tenant net lease portfolios and
include clinical, surgical, and traditional MOB properties. These
types of assets generally have shorter lease durations, greater
landlord responsibilities, longer potential downtime upon lease
maturity, and in some cases, greater potential challenges with
tenants. The characteristics of these assets can make them
attractive for a dedicated healthcare property investor and
manager, but those same characteristics can make them challenging
in the net lease space.
In total, we have identified 75 healthcare assets for sale that
account for approximately 11% of total annualized base rent (“ABR”)
with proceeds expected to be redeployed into our core industrial,
retail, and restaurant assets. On a proforma basis as of December
31, 2023, the sale of all clinically-oriented healthcare properties
will reduce our healthcare assets from 17.6% to 7.5% of our
portfolio based on ABR, and our scheduled healthcare lease
maturities through 2030 by 76.2%.
Of the properties identified for sale, we have executed
contracts on 37 healthcare properties for approximately $253.0
million at a weighted average cash capitalization rate of 7.9%,
representing a $0.8 million gain over original purchase price. The
properties represent approximately $19.9 million or 5.1% of our
December 31, 2023 ABR, 28.7% of our healthcare portfolio, and have
a weighted average remaining lease term of 4.7 years. We anticipate
the transactions will close during the first quarter of 2024. The
remaining healthcare properties identified for sale are in varying
stages of sales efforts.
Following the sales, the remaining assets in our healthcare
portfolio will consist of consumer-centric medical properties that
are customary for many publicly-traded net lease REITs, examples of
which include plasma, dialysis, and veterinary services; assets
with real estate fundamentals critical to the tenant’s business and
little to no regulatory risk. Refer to our fourth quarter 2023
investor presentation for more detailed information regarding our
healthcare portfolio simplification strategy.
As part of our healthcare portfolio simplification strategy, we
made the decision to sell Green Valley Medical Center after the
tenant failed to pay rent since October 2023 as the result of not
meeting certain operational thresholds, and we are actively
marketing the property through the date of this release. The
decision resulted in us recognizing approximately $26.4 million of
impairment during the quarter, and the tenant’s unpaid rents
represent the only outstanding rents of our 99.2% quarterly rent
collections. The tenant is responsible for all ongoing property
costs under the terms of the lease.
In reference to BNL’s healthcare portfolio simplification
strategy, John Moragne, BNL’s Chief Executive Officer, said, “As
I’ve highlighted in recent quarters, we continue to focus more
heavily on net lease industrial assets, while continuing to have
deep conviction in net lease retail and restaurant assets, and have
taken a hard look at property types that don’t fit within our
investment thesis, particularly clinical, surgical, and traditional
medical office building assets. Tenant bankruptcies, hands-on
property management, heavier landlord responsibilities and costs,
and messaging complexity in these properties has been an
unnecessary distraction from our otherwise prudent and successful
capital allocations. Our healthcare portfolio simplification
strategy is an extension of our focus on portfolio quality and
evolution, which we believe will result in meaningful value
creation for investors.”
SUMMARIZED FINANCIAL RESULTS
For the Year Ended
For the Three Months
Ended
(in thousands, except per share data)
December 31, 2023
December 31, 2022
December 31, 2023
September 30, 2023
December 31, 2022
Revenues
$
442,888
$
407,513
$
105,000
$
109,543
$
112,135
Net income, including non-controlling
interests
$
163,312
$
129,475
$
6,797
$
52,145
$
36,773
Net earnings per share - diluted
$
0.83
$
0.72
$
0.03
$
0.26
$
0.20
FFO
$
298,622
$
273,730
$
69,443
$
75,478
$
71,718
FFO per share
$
1.52
$
1.52
$
0.35
$
0.39
$
0.39
Core FFO
$
298,883
$
267,265
$
75,275
$
74,754
$
70,527
Core FFO per share
$
1.52
$
1.48
$
0.38
$
0.38
$
0.38
AFFO
$
277,725
$
252,173
$
71,278
$
69,958
$
65,585
AFFO per share
$
1.41
$
1.40
$
0.36
$
0.36
$
0.36
Diluted Weighted Average Shares
Outstanding
196,315
180,201
196,373
196,372
183,592
FFO, Core FFO, and AFFO are measures that are not calculated in
accordance with accounting principles generally accepted in the
United States of America (“GAAP”). See the Reconciliation of
Non-GAAP Measures later in this press release.
REAL ESTATE PORTFOLIO UPDATE
As of December 31, 2023, we owned a diversified portfolio of 796
individual net leased commercial properties with 789 properties
located in 44 U.S. states and seven properties located in four
Canadian provinces, comprising approximately 38.3 million rentable
square feet of operational space. As of December 31, 2023, all but
two of our properties were subject to a lease, and our properties
were occupied by 220 different commercial tenants, with no single
tenant accounting for more than 4.1% of ABR. Properties subject to
a lease represent 99.4% of our portfolio's rentable square footage.
The ABR weighted average lease term and ABR weighted average annual
minimum rent increase, pursuant to leases on properties in the
portfolio as of December 31, 2023, was 10.5 years and 2.0%,
respectively.
BALANCE SHEET AND CAPITAL MARKETS ACTIVITIES
As of December 31, 2023, we had total outstanding debt of $1.9
billion, Net Debt of $1.9 billion, and a Leverage Ratio of 5.0x. We
had $909.6 million of available capacity on our revolving credit
facility as of year end, and have no material debt maturities until
2026.
We did not raise any equity during the quarter and year, and had
approximately $145.4 million of capacity remaining on our ATM
Program as of December 31, 2023.
DISTRIBUTIONS
At its February 16, 2024, meeting, our board of directors
declared a quarterly dividend of $0.285 per common share and OP
Unit to holders of record as of March 29, 2024, payable on or
before April 15, 2024.
2024 GUIDANCE
For 2024, BNL expects to report AFFO of $1.41 per diluted
share.
The guidance is based on the following key assumptions:
(i)
investments in real estate properties between $350 million and
$700 million;
(ii)
dispositions of real estate properties between $300 million and
$500 million; and
(iii)
total cash general and administrative expenses between $32
million and $34 million.
Our per share results are sensitive to both the timing and
amount of real estate investments, property dispositions, and
capital markets activities that occur throughout the year.
The Company does not provide guidance for the most comparable
GAAP financial measure, net income, or a reconciliation of the
forward-looking non-GAAP financial measure of AFFO to net income
computed in accordance with GAAP, because it is unable to
reasonably predict, without unreasonable efforts, certain items
that would be contained in the GAAP measure, including items that
are not indicative of the Company’s ongoing operations, including,
without limitation, potential impairments of real estate assets,
net gain/loss on dispositions of real estate assets, changes in
allowance for credit losses, and stock-based compensation expense.
These items are uncertain, depend on various factors, and could
have a material impact on the Company’s GAAP results for the
guidance periods.
CONFERENCE CALL AND WEBCAST
The company will host its fourth quarter earnings conference
call and audio webcast on Thursday, February 22, 2024, at 11:00
a.m. Eastern Time.
To access the live webcast, which will be available in
listen-only mode, please visit:
https://events.q4inc.com/attendee/958546087. If you prefer to
listen via phone, U.S. participants may dial: 1-833-470-1428 (toll
free) or 1-404-975-4839 (local), access code 822981. International
access numbers are viewable here:
https://www.netroadshow.com/events/global-numbers?confId=59986.
A replay of the conference call webcast will be available
approximately one hour after the conclusion of the live broadcast.
To listen to a replay of the call via the web, which will be
available for one year, please visit:
https://investors.bnl.broadstone.com.
About Broadstone Net Lease, Inc.
BNL is an industrial-focused, diversified net lease REIT that
invests in primarily single-tenant commercial real estate
properties that are net leased on a long-term basis to a
diversified group of tenants. Utilizing an investment strategy
underpinned by strong fundamental credit analysis and prudent real
estate underwriting, as of December 31, 2023, BNL’s diversified
portfolio consisted of 796 individual net leased commercial
properties with 789 properties located in 44 U.S. states and seven
properties located in four Canadian provinces across the
industrial, healthcare, restaurant, retail, and office property
types.
Forward-Looking Statements
This press release contains “forward-looking” statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, regarding, among other things, our plans, strategies, and
prospects, both business and financial. Such forward-looking
statements can generally be identified by our use of
forward-looking terminology such as “outlook,” “potential,” “may,”
“will,” “should,” “could,” “seeks,” “approximately,” “projects,”
“predicts,” “expect,” “intends,” “anticipates,” “estimates,”
“plans,” “would be,” “believes,” “continues,” or the negative
version of these words or other comparable words. Forward-looking
statements, including our 2023 guidance and assumptions, involve
known and unknown risks and uncertainties, which may cause BNL’s
actual future results to differ materially from expected results,
including, without limitation, risks and uncertainties related to
general economic conditions, including but not limited to increases
in the rate of inflation and/or interest rates, local real estate
conditions, tenant financial health, property investments and
acquisitions, and the timing and uncertainty of completing these
property investments and acquisitions, and uncertainties regarding
future distributions to our stockholders. These and other risks,
assumptions, and uncertainties are described in Item 1A “Risk
Factors” of the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2023, which BNL expects to file with the
SEC on February 22, 2024, which you are encouraged to read, and
will be available on the SEC’s website at www.sec.gov. Should one
or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those indicated or anticipated by such
forward-looking statements. Accordingly, you are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date they are made. The Company assumes no
obligation to, and does not currently intend to, update any
forward-looking statements after the date of this press release,
whether as a result of new information, future events, changes in
assumptions, or otherwise.
Notice Regarding Non-GAAP Financial Measures
In addition to our reported results and net earnings per diluted
share, which are financial measures presented in accordance with
GAAP, this press release contains and may refer to certain non-GAAP
financial measures, including Funds from Operations (“FFO”), Core
Funds From Operations (“Core FFO”), Adjusted Funds from Operations
(“AFFO”), Net Debt, and Net Debt to Annualized Adjusted EBITDAre.
We believe the use of FFO, Core FFO, and AFFO are useful to
investors because they are widely accepted industry measures used
by analysts and investors to compare the operating performance of
REITs. FFO, Core FFO, and AFFO should not be considered
alternatives to net income as a performance measure or to cash
flows from operations, as reported on our statement of cash flows,
or as a liquidity measure, and should be considered in addition to,
and not in lieu of, GAAP financial measures. We believe presenting
Net Debt to Annualized Adjusted EBITDAre is useful to investors
because it provides information about gross debt less cash and cash
equivalents, which could be used to repay debt, compared to our
performance as measured using Annualized Adjusted EBITDAre. You
should not consider our Annualized Adjusted EBITDAre as an
alternative to net income or cash flows from operating activities
determined in accordance with GAAP. A reconciliation of non-GAAP
measures to the most directly comparable GAAP financial measure and
statements of why management believes these measures are useful to
investors are included below.
Broadstone Net Lease, Inc. and
Subsidiaries
Consolidated Balance Sheets
(in thousands, except per share
amounts)
December 31, 2023
December 31, 2022
Assets
Accounted for using the operating
method:
Land
$
748,529
$
768,667
Land improvements
328,746
340,385
Buildings and improvements
3,803,156
3,888,756
Equipment
8,265
10,422
Total accounted for using the operating
method
4,888,696
5,008,230
Less accumulated depreciation
(626,597
)
(533,965
)
Accounted for using the operating method,
net
4,262,099
4,474,265
Accounted for using the direct financing
method
26,643
27,045
Accounted for using the sales-type
method
572
571
Property under development
94,964
—
Investment in rental property, net
4,384,278
4,501,881
Cash and cash equivalents
19,494
21,789
Accrued rental income
152,724
135,666
Tenant and other receivables, net
1,487
1,349
Prepaid expenses and other assets
36,661
64,180
Interest rate swap, assets
46,096
63,390
Goodwill
339,769
339,769
Intangible lease assets, net
288,226
329,585
Total assets
$
5,268,735
$
5,457,609
Liabilities and equity
Unsecured revolving credit facility
$
90,434
$
197,322
Mortgages, net
79,068
86,602
Unsecured term loans, net
895,947
894,692
Senior unsecured notes, net
845,309
844,555
Accounts payable and other liabilities
47,534
47,547
Dividends payable
56,869
54,460
Accrued interest payable
5,702
7,071
Intangible lease liabilities, net
53,531
62,855
Total liabilities
2,074,394
2,195,104
Commitments and contingencies
Equity
Broadstone Net Lease, Inc. equity:
Preferred stock, $0.001 par value; 20,000
shares authorized, no shares issued or outstanding
—
—
Common stock, $0.00025 par value; 500,000
shares authorized, 187,614 and 186,114 shares issued and
outstanding at December 31, 2023 and 2022, respectively
47
47
Additional paid-in capital
3,440,639
3,419,395
Cumulative distributions in excess of
retained earnings
(440,731
)
(386,049
)
Accumulated other comprehensive income
49,286
59,525
Total Broadstone Net Lease, Inc.
equity
3,049,241
3,092,918
Non-controlling interests
145,100
169,587
Total equity
3,194,341
3,262,505
Total liabilities and equity
$
5,268,735
$
5,457,609
Broadstone Net Lease, Inc. and
Subsidiaries
Consolidated Statements of Income
and Comprehensive Income
(in thousands, except per share
amounts)
(Unaudited)
For the Three Months
Ended
For the Year Ended
December 31, 2023
September 30, 2023
December 31, 2023
December 31, 2022
Revenues
Lease revenues, net
$
105,000
$
109,543
$
442,888
$
407,513
Operating expenses
Depreciation and amortization
39,278
38,533
158,626
154,807
Property and operating expense
5,995
5,707
22,576
21,773
General and administrative
9,383
10,143
39,425
37,375
Provision for impairment of investment in
rental properties
29,801
—
31,274
5,535
Total operating expenses
84,457
54,383
251,901
219,490
Other (expenses) income
Interest income
141
127
512
44
Interest expense
(18,972
)
(19,665
)
(80,053
)
(78,652
)
Gain on sale of real estate
6,270
15,163
54,310
15,953
Income taxes
268
(104
)
(763
)
(1,275
)
Other (expenses) income
(1,453
)
1,464
(1,681
)
5,382
Net income
6,797
52,145
163,312
129,475
Net income attributable to non-controlling
interests
(319
)
(2,463
)
(7,834
)
(7,360
)
Net income attributable to Broadstone
Net Lease, Inc.
$
6,478
$
49,682
$
155,478
$
122,115
Weighted average number of common
shares outstanding
Basic
186,829
186,766
186,617
169,840
Diluted
196,373
196,372
196,315
180,201
Net earnings per common share
Basic
$
0.03
$
0.27
$
0.83
$
0.72
Diluted
$
0.03
$
0.26
$
0.83
$
0.72
Comprehensive income
Net income
$
6,797
$
52,145
$
163,312
$
129,475
Other comprehensive income
Change in fair value of interest rate
swaps
(32,989
)
13,943
(17,293
)
90,560
Realized loss on interest rate swaps
317
522
1,883
2,514
Comprehensive (loss) income
(25,875
)
66,610
147,902
222,549
Comprehensive loss (income) attributable
to non-controlling interests
1,215
(3,147
)
(7,070
)
(12,700
)
Comprehensive (loss) income attributable
to Broadstone Net Lease, Inc.
$
(24,660
)
$
63,463
$
140,832
$
209,849
Reconciliation of Non-GAAP Measures
The following is a reconciliation of net income to FFO, Core
FFO, and AFFO for the three months ended December 31, 2023 and
September 30, 2023 and for the year ended December 31, 2023 and
2022. Also presented is the weighted average number of shares of
our common stock and OP Units used for the diluted per share
computation:
For the Three Months
Ended
For the Year Ended
(in thousands, except per share data)
December 31, 2023
September 30, 2023
December 31, 2023
December 31, 2022
Net income
$
6,797
$
52,145
$
163,312
$
129,475
Real property depreciation and
amortization
39,115
38,496
158,346
154,673
Gain on sale of real estate
(6,270
)
(15,163
)
(54,310
)
(15,953
)
Provision for impairment on investment in
rental properties
29,801
—
31,274
5,535
FFO
$
69,443
$
75,478
$
298,622
$
273,730
Net write-offs of accrued rental
income
4,161
—
4,458
1,326
Lease termination fees
—
—
(7,500
)
(2,469
)
Cost of debt extinguishment
—
—
—
(341
)
Gain on insurance recoveries
—
—
3
308
Severance and executive transition
costs
218
740
1,622
401
Other expenses (income)(1)
1,453
(1,464
)
1,678
(5,690
)
Core FFO
$
75,275
$
74,754
$
298,883
$
267,265
Straight-line rent adjustment
(5,404
)
(6,785
)
(26,736
)
(21,900
)
Adjustment to provision for credit
losses
—
—
(10
)
(5
)
Amortization of debt issuance costs
983
983
3,938
3,692
Amortization of net mortgage premiums
—
—
(78
)
(104
)
Loss on interest rate swaps and other
non-cash interest expense
319
522
1,884
2,514
Amortization of lease intangibles
(1,014
)
(1,056
)
(5,846
)
(4,809
)
Stock-based compensation
1,401
1,540
5,972
5,316
Deferred taxes
(282
)
—
(282
)
204
AFFO
$
71,278
$
69,958
$
277,725
$
251,969
Diluted WASO(2)
196,373
196,372
196,315
180,201
Net earnings per diluted share(3)
$
0.03
$
0.26
$
0.83
$
0.72
FFO per share(3)
0.35
0.39
1.52
1.52
Core FFO per share(3)
0.38
0.38
1.52
1.48
AFFO per share(3)
0.36
0.36
1.41
1.40
1
Amount includes $1.5 million and $(1.4)
million of unrealized foreign exchange loss (gain) for the three
months ended December 31, 2023 and September 30, 2023,
respectively, and $1.7 and $(5.6) million of unrealized foreign
exchange loss (gain) for the year ended December 31, 2023 and 2022,
primarily associated with our Canadian dollar denominated revolving
borrowings.
2
Excludes 493,524 and 506,172 weighted
average shares of unvested restricted common stock for the three
months ended December 31, 2023 and September 30, 2023,
respectively. Excludes 492,046 and 396,383 weighted average shares
of unvested restricted common stock for the year ended December 31,
2023 and 2022, respectively.
3
Excludes $0.1 million from the numerator
for the three months ended December 31, 2023 and September 30,
2023, respectively, and $0.5 million and $0.4 million from the
numerator for the year ended December 31, 2023 and 2022,
respectively, related to dividends paid or declared on shares of
unvested restricted common stock.
Our reported results and net earnings per diluted share are
presented in accordance with GAAP. We also disclose FFO, Core FFO,
and AFFO, each of which are non-GAAP measures. We believe the use
of FFO, Core FFO, and AFFO are useful to investors because they are
widely accepted industry measures used by analysts and investors to
compare the operating performance of REITs. FFO, Core FFO, and AFFO
should not be considered alternatives to net income as a
performance measure or to cash flows from operations, as reported
on our statement of cash flows, or as a liquidity measure and
should be considered in addition to, and not in lieu of, GAAP
financial measures.
We compute FFO in accordance with the standards established by
the Board of Governors of Nareit, the worldwide representative
voice for REITs and publicly traded real estate companies with an
interest in the U.S. real estate and capital markets. Nareit
defines FFO as GAAP net income or loss adjusted to exclude net
gains (losses) from sales of certain depreciated real estate
assets, depreciation and amortization expense from real estate
assets, and impairment charges related to certain previously
depreciated real estate assets. FFO is used by management,
investors, and analysts to facilitate meaningful comparisons of
operating performance between periods and among our peers,
primarily because it excludes the effect of real estate
depreciation and amortization and net gains (losses) on sales,
which are based on historical costs and implicitly assume that the
value of real estate diminishes predictably over time, rather than
fluctuating based on existing market conditions.
We compute Core FFO by adjusting FFO, as defined by Nareit, to
exclude certain GAAP income and expense amounts that we believe are
infrequently recurring, unusual in nature, or not related to its
core real estate operations, including write-offs or recoveries of
accrued rental income, lease termination fees, gain on insurance
recoveries, cost of debt extinguishments, unrealized and realized
gains or losses on foreign currency transactions, severance and
executive transition costs, and other extraordinary items.
Exclusion of these items from similar FFO-type metrics is common
within the equity REIT industry, and management believes that
presentation of Core FFO provides investors with a metric to assist
in their evaluation of our operating performance across multiple
periods and in comparison to the operating performance of our
peers, because it removes the effect of unusual items that are not
expected to impact our operating performance on an ongoing
basis.
We compute AFFO by adjusting Core FFO for certain non-cash
revenues and expenses, including straight-line rents, amortization
of lease intangibles, adjustment to provision for credit losses,
amortization of debt issuance costs, amortization of net mortgage
premiums, (gain) loss on interest rate swaps and other non-cash
interest expense, deferred taxes, stock-based compensation, and
other specified non-cash items. We believe that excluding such
items assists management and investors in distinguishing whether
changes in our operations are due to growth or decline of
operations at our properties or from other factors. We use AFFO as
a measure of our performance when we formulate corporate goals, and
is a factor in determining management compensation. We believe that
AFFO is a useful supplemental measure for investors to consider
because it will help them to better assess our operating
performance without the distortions created by non-cash revenues or
expenses.
Specific to our adjustment for straight-line rents, our leases
include cash rents that increase over the term of the lease to
compensate us for anticipated increases in market rental rates over
time. Our leases do not include significant front-loading or
back-loading of payments, or significant rent-free periods.
Therefore, we find it useful to evaluate rent on a contractual
basis as it allows for comparison of existing rental rates to
market rental rates.
FFO, Core FFO, and AFFO may not be comparable to similarly
titled measures employed by other REITs, and comparisons of our
FFO, Core FFO, and AFFO with the same or similar measures disclosed
by other REITs may not be meaningful.
Neither the SEC nor any other regulatory body has passed
judgment on the acceptability of the adjustments to FFO that we use
to calculate Core FFO and AFFO. In the future, the SEC, Nareit or
another regulatory body may decide to standardize the allowable
adjustments across the REIT industry and in response to such
standardization we may have to adjust our calculation and
characterization of Core FFO and AFFO accordingly.
The following is a reconciliation of net income to EBITDA,
EBITDAre, and Adjusted EBITDAre, debt to Net Debt and Net Debt to
Annualized Adjusted EBITDAre as of and for the three months ended
December 31, 2023, September 30, 2023, and December 31, 2022:
For the Three Months
Ended
(in thousands)
December 31, 2023
September 30, 2023
December 31, 2022
Net income
$
6,797
$
52,145
$
36,773
Depreciation and amortization
39,278
38,533
45,606
Interest expense
18,972
19,665
23,773
Income taxes
(268
)
104
105
EBITDA
$
64,779
$
110,447
$
106,257
Provision for impairment of investment in
rental properties
29,801
—
—
Gain on sale of real estate
(6,270
)
(15,163
)
(10,625
)
EBITDAre
$
88,310
$
95,284
$
95,632
Adjustment for current quarter investment
activity (1)
153
26
1,283
Adjustment for current quarter disposition
activity (2)
(156
)
(400
)
(440
)
Adjustment to exclude non-recurring and
other expenses (income) (3)
128
740
—
Adjustment to exclude net write-offs of
accrued rental income
4,161
—
—
Adjustment to exclude gain on insurance
recoveries
—
—
(341
)
Adjustment to exclude realized /
unrealized foreign exchange (gain) loss
1,453
(1,433
)
796
Adjustment to exclude cost of debt
extinguishments
—
—
77
Adjustment to exclude lease termination
fees
—
—
(1,678
)
Adjusted EBITDAre
$
94,049
$
94,217
$
95,329
Annualized EBITDAre
$
353,240
$
381,136
$
382,528
Annualized Adjusted EBITDAre
$
376,196
$
376,868
$
381,316
1
Reflects an adjustment to give effect to
all investments during the quarter as if they had been made as of
the beginning of the quarter.
2
Reflects an adjustment to give effect to
all dispositions during the quarter as if they had been sold as of
the beginning of the quarter.
3
Amount includes $0.2 million of employee
severance and executive transition costs and ($0.1) million of
forfeited stock-based compensation for the three months ended
December 31, 2023 and $0.7 million of employee severance and
executive transition costs during the three months ended September
30, 2023.
(in thousands)
December 31, 2023
September 30, 2023
December 31, 2022
Debt
Unsecured revolving credit facility
$
90,434
$
74,060
$
197,322
Unsecured term loans, net
895,947
895,633
894,692
Senior unsecured notes, net
845,309
845,121
844,555
Mortgages, net
79,068
79,613
86,602
Debt issuance costs
8,848
9,360
10,905
Gross Debt
1,919,606
1,903,787
2,034,076
Cash and cash equivalents
(19,494
)
(35,061
)
(21,789
)
Restricted cash
(1,138
)
(15,436
)
(38,251
)
Net Debt
$
1,898,974
$
1,853,290
$
1,974,036
Net Debt to Annualized EBITDAre
5.4x
4.9x
5.2x
Net Debt to Annualized Adjusted
EBITDAre
5.0x
4.9x
5.2x
We define Net Debt as gross debt (total reported debt plus debt
issuance costs) less cash and cash equivalents and restricted cash.
We believe that the presentation of Net Debt to Annualized EBITDAre
and Net Debt to Annualized Adjusted EBITDAre is useful to investors
and analysts because these ratios provide information about gross
debt less cash and cash equivalents, which could be used to repay
debt, compared to our performance as measured using EBITDAre.
We compute EBITDA as earnings before interest, income taxes and
depreciation and amortization. EBITDA is a measure commonly used in
our industry. We believe that this ratio provides investors and
analysts with a measure of our performance that includes our
operating results unaffected by the differences in capital
structures, capital investment cycles and useful life of related
assets compared to other companies in our industry. We compute
EBITDAre in accordance with the definition adopted by Nareit, as
EBITDA excluding gains (losses) from the sales of depreciable
property and provisions for impairment on investment in real
estate. We believe EBITDA and EBITDAre are useful to investors and
analysts because they provide important supplemental information
about our operating performance exclusive of certain non-cash and
other costs. EBITDA and EBITDAre are not measures of financial
performance under GAAP, and our EBITDA and EBITDAre may not be
comparable to similarly titled measures of other companies. You
should not consider our EBITDA and EBITDAre as alternatives to net
income or cash flows from operating activities determined in
accordance with GAAP.
We are focused on a disciplined and targeted investment
strategy, together with active asset management that includes
selective sales of properties. We manage our leverage profile using
a ratio of Net Debt to Annualized Adjusted EBITDAre, discussed
below, which we believe is a useful measure of our ability to repay
debt and a relative measure of leverage, and is used in
communications with our lenders and rating agencies regarding our
credit rating. As we fund new investments using our unsecured
revolving credit facility, our leverage profile and Net Debt will
be immediately impacted by current quarter investments. However,
the full benefit of EBITDAre from new investments will not be
received in the same quarter in which the properties are acquired.
Additionally, EBITDAre for the quarter includes amounts generated
by properties that have been sold during the quarter. Accordingly,
the variability in EBITDAre caused by the timing of our investments
and dispositions can temporarily distort our leverage ratios. We
adjust EBITDAre (“Adjusted EBITDAre”) for the most recently
completed quarter (i) to recalculate as if all investments and
dispositions had occurred at the beginning of the quarter, (ii) to
exclude certain GAAP income and expense amounts that are either
non-cash, such as cost of debt extinguishments, realized or
unrealized gains and losses on foreign currency transactions, or
gains on insurance recoveries, or that we believe are one time, or
unusual in nature because they relate to unique circumstances or
transactions that had not previously occurred and which we do not
anticipate occurring in the future, and (iii) to eliminate the
impact of lease termination fees and other items, that are not a
result of normal operations. While investments in property
developments have an immediate impact to Net Debt, we do not make
an adjustment to EBITDAre until the quarter in which the lease
commences. We then annualize quarterly Adjusted EBITDAre by
multiplying it by four (“Annualized Adjusted EBITDAre”). You should
not unduly rely on this measure as it is based on assumptions and
estimates that may prove to be inaccurate. Our actual reported
EBITDAre for future periods may be significantly different from our
Annualized Adjusted EBITDAre. Adjusted EBITDAre and Annualized
Adjusted EBITDAre are not measurements of performance under GAAP,
and our Adjusted EBITDAre and Annualized Adjusted EBITDAre may not
be comparable to similarly titled measures of other companies. You
should not consider our Adjusted EBITDAre and Annualized Adjusted
EBITDAre as alternatives to net income or cash flows from operating
activities determined in accordance with GAAP.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240221682114/en/
Company: Brent Maedl Director, Corporate Finance &
Investor Relations brent.maedl@broadstone.com 585.382.8507
Broadstone Net Lease (NYSE:BNL)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Broadstone Net Lease (NYSE:BNL)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025